Kestra Medical Technologies, Ltd.
KMTS
$16.55
-$0.42-2.48%
NASDAQ
| 04/30/2025 | 01/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 14.20% | 9.78% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.20% | 9.78% | |||
| Cost of Revenue | 12.37% | -2.15% | |||
| Gross Profit | 16.59% | 30.55% | |||
| SG&A Expenses | 112.06% | 16.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 83.37% | 9.72% | |||
| Operating Income | -134.03% | -9.68% | |||
| Income Before Tax | -134.62% | -6.24% | |||
| Income Tax Expenses | 466.67% | 140.00% | |||
| Earnings from Continuing Operations | -134.90% | -6.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -476.80% | -27.75% | |||
| Net Income | -142.01% | -6.87% | |||
| EBIT | -134.03% | -9.68% | |||
| EBITDA | -147.83% | -12.32% | |||
| EPS Basic | -80.27% | 99.42% | |||
| Normalized Basic EPS | -99.03% | 99.43% | |||
| EPS Diluted | -80.27% | 99.42% | |||
| Normalized Diluted EPS | -99.03% | 99.43% | |||
| Average Basic Shares Outstanding | 23.63% | 18,695.27% | |||
| Average Diluted Shares Outstanding | 23.63% | 18,695.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||